Results 231 to 240 of about 101,408 (263)

Chemotherapy is associated with differential survival outcomes in apocrine carcinoma: A nationwide cohort study from the Japanese National Clinical Database-Breast Cancer Registry. [PDF]

Breast
Horimoto Y, Kumamaru H, Orimoto K, Ishikawa T, Kinukawa N, Iwamoto T, Taira N, Ishida T.   +7 more
europepmc   +1 more source

Single‐Cell Profiling Identifies SLC2A5‐Mediated Fructose Metabolism as a Vulnerability in Primary CNS Lymphoma

Advanced Science, EarlyView.
Glucose deprivation in the primary CNS lymphoma (PCNSL) tumor microenvironment drives SLC2A5 (encoding GLUT5)‐dependent fructose metabolism in tumor cells, while hypoxia induces HIF‐mediated SLC2A5 expression in tumor‐supportive macrophages, revealing SLC2A5‐driven fructose utilization as a shared and targetable metabolic vulnerability across malignant
Qiaoli Wu, Qianru Zhang, Wenqiang Yan, Lu Sun, Yiran Cui, Bolin Liu, Guoqing Han, Feng Zhang, Ke Pu, Mingchao Zhang, Xiaobing Zhang, Qingguo Li, Gang An, Yuxuan Liu   +13 more
wiley   +1 more source

Mixed Invasive Adenoid Cystic and Lobular Carcinoma of the Breast: A Case Report of a Rare Hybrid Tumor. [PDF]

Cureus
Babker MS, Chavarria H.
europepmc   +1 more source

A Solution for Exosome‐Based Analysis: Surface‐Enhanced Raman Spectroscopy and Artificial Intelligence

Advanced Intelligent Discovery, EarlyView.
Exosomes are emerging as powerful biomarkers for disease diagnosis and monitoring. This review highlights the integration of surface‐enhanced Raman spectroscopy with artificial intelligence to enhance molecular fingerprinting of exosomes. Machine learning and deep learning techniques improve spectral interpretation, enabling accurate classification of ...
Munevver Akdeniz, Zakarya Al‐Shaebi, Omer Aydin   +2 more
wiley   +1 more source

PIK3CA mutation detection by circulating tumor cell sequencing guides the effective PI3K inhibitor treatment of a patient with hormone receptor-positive breast cancer transformed into triple-negative breast cancer: A case report. [PDF]

Medicine (Baltimore)
Zhang J, Pei J, Hao G, Meng Y, Li F, Xu H, Liu H.   +6 more
europepmc   +1 more source

AI‐Driven Cancer Multi‐Omics: A Review From the Data Pipeline Perspective

Advanced Intelligent Discovery, EarlyView.
The exponential growth of cancer multi‐omics data brings opportunities and challenges for precision oncology. This review systematically examines AI's role in addressing these challenges, covering generative models, integration architectures, Explainable AI for clinical trust, clinical applications, and key directions for clinical translation.
Shilong Liu, Shunxiang Li, Kun Qian
wiley   +1 more source

A bibliometric analysis of global research trends in adoptive cell therapy for triple negative breast cancer over the past 15 years. [PDF]

Discov Oncol
Elenien WIA, Ibrahim NA, Mohamed M, Elenien YA, Heiba M, Abouelenin O, Mahmood DA, Hussein FK.   +7 more
europepmc   +1 more source

Lines Left Uncrossed: The Cost of Attrition in Metastatic Triple Negative Breast Cancer. [PDF]

Cureus
Devi R N, Krishnan M P A, Shenoy PK, Menon A.   +3 more
europepmc   +1 more source

Co-Pathogenic Role of BRCA1 and OBSCN Deletions in Chinese Familial Breast Cancer: A Case Report. [PDF]

Am J Case Rep
Yi L, Chen K, Wang D, Wang R, Zhu X, Chai J, Jia X, Xu F, Gu M, Cui C, Zhang W.   +10 more
europepmc   +1 more source

Association of Tumor Stage and Molecular Subtype With Three-Year Recurrence Outcomes After Adjuvant Radiotherapy in Stage I-III Breast Cancer: A Single-Centre 2022 Cohort Study. [PDF]

Cureus
Nazar N, Ghumman AR, Waqar AS, Sahi MA, Ilyas A, Haider N.   +5 more
europepmc   +1 more source